DWS ESG Biotech TFC
WKN DWS2UA | ISIN DE000DWS2UA1 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | CH0113817123 | Bellevue Biotech DT CHF | +10,49 % | +18,36 % | 0,43 |
|
| 2 | LU1269736838 | Candriam Equities L Biotech.R EUR Acc | +9,53 % | +18,06 % | 0,39 |
|
| 3 | LU1120766032 | Candriam Equities L Biotech.I EUR Acc | +9,17 % | +17,80 % | 0,37 |
|
| 4 | IE00B3WVRB16 | Polar Capital Funds plc - Biotechnology Fund Class I EUR Distribution Shares | +9,76 % | +19,42 % | 0,37 |
|
| 5 | LU1120766388 | Candriam Equities L Biotech.C EUR | +8,52 % | +18,05 % | 0,33 |
|
| 41 | DE000DWS2UA1 | DWS ESG Biotech TFC | +1,97 % | +20,06 % | -0,03 |
|
| 73 | LU0320765992 | Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) SGD | -5,11 % | +18,58 % | -0,41 |
|
| 74 | LU1803069274 | F.Biotechnology Dis.Fd.A-H1 EUR H | -6,11 % | +18,98 % | -0,46 |
|
| 75 | LU0959058974 | Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 | -8,54 % | +19,01 % | -0,58 |
|
| 76 | DE000A3DCA95 | BIT Biotech Opportunities S | -16,77 % | +30,27 % | -0,64 |
|
| 77 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -17,26 % | +30,26 % | -0,65 |
|